Literature DB >> 18200472

Two adult cases of coronary artery aneurysms secondary to Kawasaki disease.

A Kitamura1, N Mukohara, N Ozaki, M Yoshida, T Shida.   

Abstract

Kawasaki disease (KD) is an acute, self-limiting vasculitis that occurs in children of all ages, which was first described by Kawasaki in 1967. The fatal complication of KD is coronary artery involvement resulting in coronary artery aneurysms. We report on two adult cases with coronary artery aneurysms secondary to childhood KD who underwent coronary artery bypass grafting (CABG) using multiple arterial grafts. There have been few reports of cardiovascular surgery in adult survivors of KD.

Entities:  

Mesh:

Year:  2008        PMID: 18200472     DOI: 10.1055/s-2007-965056

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

Review 1.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

2.  Missed Kawasaki disease in childhood presenting as myocardial infarction in adults.

Authors:  Ajit Bhagwat; Sachin Mukhedkar; Shriganesh Ekbote; John B Gordon
Journal:  Indian Heart J       Date:  2015-05-14

3.  Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis.

Authors:  Antonio Salsano; Jingda Liao; Ambra Miette; Massimo Capoccia; Giovanni Mariscalco; Francesco Santini; Antonio F Corno
Journal:  Open Med (Wars)       Date:  2021-03-09

4.  ST-segment elevation myocardial infarction in Kawasaki disease: A case report and review of literature.

Authors:  Joonpyo Lee; Jeongduk Seo; Yong Hoon Shin; Albert Youngwoo Jang; Soon Yong Suh
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

Review 5.  Cardiac surgical procedures for the coronary sequelae of Kawasaki disease.

Authors:  Shi-Min Yuan
Journal:  Libyan J Med       Date:  2012-12-03       Impact factor: 1.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.